TORONTO, ON / ACCESSWIRE / October 30, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (CSE:MPXI)(OTCPINK:MPXOF) today announced that W. Scott Boyes, Chairman, CEO and President of MPXI, and Randall Stafford, a Director of MPXI, have, during the month of October 2019, executed open-market purchases of an aggregate of 1,271,000 common shares of MPXI (the “MPXI Shares”) for the aggregate purchase price of CDN$597,094.
Mr. Boyes purchased 800,000 MPXI Shares with an average cost of CDN$0.482 per MPXI Share for a total purchase amount of CDN$385,788. Mr. Stafford has acquired 471,150 MPXI Shares at an average of CDN$0.448 per MPXI Share for a total purchase price of CDN$211,306.
We continue to be very excited about the rapidly emerging global medical cannabis marketplace. With over 35 countries having now legalized medical cannabis, the industry is entering a phase of rapid international expansion.
W. Scott Boyes, Chairman, CEO and President of MPXI
As MPXI continues to develop its operations in the UK, Malta, Switzerland, Australia, South Africa, Canada and elsewhere, I am ever-more confident that our company is well-positioned for near-term growth and profitability and for the creation of long-term value for its shareholders.
About MPX International Corporation
MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.
